Luis Figuero-Pérez

11PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursInnate immunityPredictive and prognostic markersCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 15, 2026
Effectiveness of the ALMA Intervention on Cognitive Function in Women with Breast Cancer: Protocol for a Randomized Controlled Trial.

|Feb 02, 2024
A rare case of hepatoid gastric adenocarcinoma.

Elena Pablo-Martín, Laura Corvo-Félix, Jonnathan Roldán Ruiz

|Oct 26, 2023
Late recurrence of lobular breast carcinoma presented as gastric metastasis.

Luis Posado-Domínguez, Luis Figuero Pérez, Laura Corvo-Felix

|Sep 09, 2023
Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data.

Irene Toribio-García, Alejandro Olivares-Hernández, José Pablo Miramontes-González

|Feb 25, 2022
Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis.

Alejandro Olivares-Hernández, Edel Del Barco Morillo, Carmen Parra Pérez

|Dec 24, 2021
Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors.

Alejandro Olivares-Hernández, Luis Figuero-Pérez, José Pablo Miramontes-González

Pageof 2

Frequent Collaborators

5 joint publications

José Pablo Miramontes-González

4 joint publications

Juan Jesus Cruz-Hernandez

4 joint publications

Rogelio González-Sarmiento

2 joint publications

Luis Posado-Domínguez